USPH in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with USPH today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
U.S. Physical Therapy helps patients recover from surgery, orthopedic conditions, sports injuries and workplace injuries. It usually operates clinics through partnerships in which the company owns a majority stake and a local therapist owns the remaining interest and runs the clinic. It also provides speech and occupational therapy and some care at patients’ homes. Patient treatment supplies most of its revenue. Managed care plans and commercial insurers are the largest payor group, while the government health programs Medicare and Medicaid provide a substantial share. Clinics generally bill for individual treatment procedures.
A smaller business sends specialists to employers’ workplaces to prevent injuries and provide rehabilitation. Employers contract for and directly pay for most of these services. The company also earns fees for managing and staffing therapy services for hospitals and other providers it does not own.
The clinic business depends on local physicians referring patients, enough qualified therapists to treat them, and insurers’ and government programs’ reimbursement rates and coverage rules. State laws restricting corporate provision of therapy and fee-sharing also constrain how the company structures its relationships with clinicians and providers.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
U.S. Physical Therapy’s results depend more on rehabilitation visits, physician referrals, therapist costs and commercial-insurance and Medicare reimbursement than on the broader healthcare businesses represented here.
Omada Health competes with U.S. Physical Therapy’s rehabilitation and employer-paid injury services by offering online muscle and joint care from licensed physical therapists to employers and health plans. Its Omada for MSK program is the business to watch for competition over those customers, rather than its diabetes and weight-management programs.
The Pennant Group overlaps with U.S. Physical Therapy’s home-care therapy business by providing physical, occupational and speech therapy in patients’ homes, with payments across its businesses coming from government programs, private-pay patients and residents, and managed care payors. Its home-health therapy business offers the closer comparison; hospice and senior living make its overall results less directly comparable.
Fed Interest Rate Decision
The Fed’s rate decision signals whether borrowing costs across the economy are rising or falling, which can change what U.S. Physical Therapy pays on its $161.8 million in borrowings as its debt reprices.
Expected4.0%Last release4.0%
If it comes in above expectations
If the policy rate is higher than expected, variable-rate debt that reprices can cost U.S. Physical Therapy more to service, leaving less cash for clinic and IIP operations.
If it comes in below expectations
If the policy rate is lower than expected, variable-rate debt that reprices can cost U.S. Physical Therapy less to service, leaving more cash for clinic and IIP operations.
US Physical Therapy Inc earningsThis company
U.S. Physical Therapy’s therapy and workplace injury-prevention businesses pay to staff and deliver their services, and this report will show whether revenue growth is lifting gross profit in both segments.
Compare revenue with segment gross profit for physical therapy operations and industrial injury prevention services (IIP), separately. If revenue and gross profit both rise in each, added services are contributing after direct service costs; if revenue rises but gross profit is flat or falls, staffing or delivery costs are absorbing the growth. The comparison shows whether growth is improving profitability in both businesses.
The Pennant Group, Inc. earningsPNTG
The Pennant Group’s home-health therapy business overlaps with U.S. Physical Therapy’s home-care services, so its report offers a read on demand and revenue in that part of the therapy market.
Focus on Pennant’s home-health therapy business, not its company-wide results, which also include hospice and senior living. If activity and therapy revenue strengthen, that suggests firmer demand for home-based care, a supportive market signal for U.S. Physical Therapy’s home-care services; if both weaken, the market may be softening, though that does not establish how U.S. Physical Therapy performed.
Omada Health, Inc. earningsOMDA
Omada Health’s online musculoskeletal (MSK) care targets employers and health plans, and its report can show whether demand for that service is intensifying competition for U.S. Physical Therapy’s rehabilitation and employer injury-service customers.
Watch demand and revenue for Omada for MSK, not its diabetes or weight-management programs. Strength there would show employers and health plans are buying more online musculoskeletal care, signaling tougher competition for U.S. Physical Therapy’s rehabilitation and employer injury-service customers; weakness would ease that competitive signal, but would not prove customers shifted to U.S. Physical Therapy.